home / stock / rptx / rptx news


RPTX News and Press, Repare Therapeutics Inc. From 10/13/23

Stock Information

Company Name: Repare Therapeutics Inc.
Stock Symbol: RPTX
Market: NASDAQ
Website: reparerx.com

Menu

RPTX RPTX Quote RPTX Short RPTX News RPTX Articles RPTX Message Board
Get RPTX Alerts

News, Short Squeeze, Breakout and More Instantly...

RPTX - Repare Therapeutics Announces Positive Initial Data from Phase 1 MYTHIC Clinical Trial Evaluating Lunresertib Alone and in Combination with Camonsertib

Lunresertib + camonsertib combination demonstrated clear signals of anti-tumor activity across multiple tumor types and all selected genotypes Overall response of 33.3% across all tumor types and 50% RECIST response in patients with heavily pre-treated gynecologic tumors, including endome...

RPTX - Repare Therapeutics: A Compelling Bet On Synthetic Lethality

2023-10-03 09:00:00 ET Summary Repare Therapeutics shows clinical and financial strength, with diverse cancer therapies and a robust balance sheet. Despite promising Q2 results, elevated put activity and 7.32% short interest warrant investor caution. "Buy" recommendation based...

RPTX - Repare Therapeutics to Host Conference Call and Webcast to Discuss Initial Phase 1 MYTHIC Modules 1 and 2 Clinical Data Presented at 35th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Conference call and live webcast on Friday, October 13, 2023 at 5:30 p.m. ET Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced it will host a conference call and live webc...

RPTX - Repare Therapeutics to Present Preliminary Phase 1 MYTHIC Module 1 and 2 Data at 35th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced it will present initial data from Module 1 and 2 of its ongoing Phase 1 MYTHIC clinical trial in a plenary session at the upcoming ...

RPTX - Repare Therapeutics to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate in a fireside chat at the Morgan Stanley 21 st Annual Global Health...

RPTX - SWAV, STKL and PSTX are among after hour movers

2023-08-16 17:38:56 ET Gainers: Avnet ( AVT ) +8% . SunOpta ( STKL ) +8% . StoneCo ( STNE ) +5% . Repare Therapeutics  ( RPTX ) +5% . ARS Pharmaceuticals ( SPRY ) +5% . Losers: The Lovesac  ( LOVE ) -7% ...

RPTX - Wall Street Thinks This Cathie Wood Stock Could Jump by 187%

2023-08-16 14:54:00 ET Cathie Wood, the founder and CEO of ARK Investment Management, is one of the most influential investors in the area of cutting-edge technology. She's known for her bullish bets on disruptive and innovative companies such as Tesla , Roku , and Shopify . ...

RPTX - LGHL and EBIX among mid-day movers

2023-08-10 13:25:55 ET Gainers: WeWork ( WE ) +87% . Capri Holdings Limited ( CPRI ) +56% . Black Spade Acquisition ( BSAQ ) +58% . Edible Garden AG Incorporated ( EDBL ) +43% . Lion Group Holding Ltd. ( LGHL ) +37% . Precige...

RPTX - Repare Therapeutics Inc. (NASDAQ: RPTX) Near the Top of Equities by Percentage Gain on 8/10

Repare Therapeutics Inc. (NASDAQ: RPTX) is one of today's top gainers. The company's shares are currently up 20.07% on the day to $10.11. Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Cana...

RPTX - LifeMD, Precigen top healthcare gainers; Galera, Virios lead losers' pack

2023-08-10 10:27:32 ET Gainers: LifeMD ( LFMD ) +20% . Precigen ( PGEN ) +19% . Repare Therapeutics ( RPTX ) +16% . Cosmos Health ( COSM ) +13% . GoodRx Holdings ( GDRX ) +13% . Losers: Galera Therapeutics ( GRTX ) -...

Previous 10 Next 10